Ronilda D’Cunha

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 92 citations · Full text

TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp‐ and BCRP‐mediated efflux

Ronilda D’Cunha, SoHyun Bae, Daryl J. Murry et al. · Biopharmaceutics & Drug Disposition · 2016 · 48 citations

Efficacy and Safety of <scp>ABBV</scp>‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with <scp>Moderate‐to‐Severe</scp> Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, <scp>Double‐Blind</scp>, <scp>Active‐Controlled Proof‐of‐Concept</scp> Phase <scp>IIa</scp> Trial

Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich et al. · Arthritis & Rheumatology · 2022 · 44 citations · Full text

Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation

Ronilda D’Cunha, Thanh Bach, Beth Ann Young et al. · Antimicrobial Agents and Chemotherapy · 2018 · 38 citations · Full text

Antimicrobial Chemotherapy, Pharmacodynamic Modeling, Robust Method +28

Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation

Ronilda D’Cunha, Thanh Bach, Beth Ann Young et al. · Antimicrobial Agents and Chemotherapy · 2018 · 26 citations · Full text

Pharmaceutical Science, Whole Blood, Antimicrobial Chemotherapy +24